To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Richard A. CollinsRichard Anthony Collins (born 18 February, 1966) is a British scientist. Product highlightLifeRichard A Collins was born in Singapore, where his father was a member of the Royal Air Force. The family returned to the UK shortly after his birth. Collins underwent his secondary education in Grimsby, England before going on to study at the University of Dundee where he obtained a Bachelor of Science (Honours) Biochemistry degree in 1988 and a Master of Science degree in Analytical Biochemistry in 1990. He obtained his PhD in Biochemistry from the University of Edinburgh in 1994. He did post-doctoral research on natural products with anti-viral properties in the USA and Hong Kong. He has published numerous peer reviewed scientific articles on his work in the areas of HIV-1 inhibition,[1] [2][3] and novel nucleic acid based diagnostics for avian influenza,[4][5][6][7][8] severe acute respiratory syndrome (SARS),[9] and foot-and-mouth disease.[10][11][12] Collins is a member of several professional scientific organisations, notably a Chartered Chemist and Fellow of the Royal Society of Chemistry (CChem, FRSC), a Chartered Biologist and Fellow of the Institute of Biology (CBiol, FIBiol) and a Fellow of the Institute of Biomedical Science (FIBMS). References
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Richard_A._Collins". A list of authors is available in Wikipedia. |
- Size_exclusion_chromatography
- Reflux_suppressant
- Meda Pharma S.p.A. - Mailand, Italie
- New guidelines for development and approval of biosimilars move closer - EuropaBio welcomes the direct dialogue and calls upon the EU to settle all outstanding important issues before the first biosimilars enter the market
- Wissenschaftler passen Astronomie-Methode an, um Mikroskopie-Bilder schärfer zu machen - Neue Methode für klarere Bilder von dicken biologischen Proben



